NCT04569903View on ClinicalTrials.gov

Evaluation of a Claims-based Algorithm for the Identification of Transthyretin-mediated Amyloidosis (ATTR) Amyloidosis in Medical Records

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

August 1, 2022

Primary Completion Date

February 1, 2025

Study Completion Date

February 1, 2025

Conditions
Transthyretin Amyloidosis
Interventions
DEVICE

Computer algorithm for ATTR

Patients will be evaluated for the identification of ATTR Amyloidosis through a claims-based algorithm

Trial Locations (1)

06520

Yale New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
collaborator

Alnylam Pharmaceuticals Inc

UNKNOWN

lead

Yale University

OTHER